Adagene Inc. American Depositary Shares (ADAG) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Adagene Inc. American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.67
+3.49% today
Market cap
$170M
Overall quality
38/100
Kronos AI 30-day
+31.8%
8 of 8 simulated paths end higher
Adagene Inc. American Depositary Shares (ADAG) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $170M. It trades at $2.67, up 3.49% today. Its overall quality score is 38 out of 100, ranked against the whole US market. 5 analysts' average target of $8.50 implies +218.4% from today's price. Kronos AI's 30-day forecast is +31.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $8.50 |
| Low – high | $7.00 – $10.00 |
| Analysts | 5 |
| Upside to average | +218.4% |
Kronos AI 30-day forecast
| Expected close | $3.40 (+31.8%) |
| Likely range | +25.0% … +38.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 14 |
| Solvency | 59 |
| Growth | 41 |
| Overall | 38 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.